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doi:10.1016/j.jtcvs.2006.08.068bjective: Uncorrected functional tricuspid regurgitation has serious long-term
orbidity and mortality. We reviewed our experience with tricuspid posterior
nnular bicuspidization versus ring tricuspid annuloplasty for treatment of func-
ional tricuspid regurgitation.
ethods: From 1999 to 2003, 237 patients underwent tricuspid annuloplasty for
unctional tricuspid regurgitation as part of their cardiac surgical procedure. Bicus-
idization was performed in 157 patients and ring annuloplasty in 80 patients.
reoperatively, 227 (96%) patients had moderate or greater tricuspid regurgitation
ith a median regurgitation of 3. Follow-up information was obtained for 234
99%) patients with a mean follow-up time of 3 years. Postoperative transthoracic
chocardiograms were assessed for severity of tricuspid regurgitation. Moderate or
reater tricuspid regurgitation was considered significant. Survival and development
f recurrent tricuspid regurgitation were evaluated by Kaplan–Meier analysis.
ricuspid regurgitation and risk factors for recurrent regurgitation were identified
nd analyzed by multivariable ordinal longitudinal methods.
esults: At 3 years postoperatively, tricuspid regurgitation in patients treated by
icuspidization annuloplasty was zero to mild in 75%, moderate in 11%, moderate
o severe in 6%, and severe in 8% of patients. In those undergoing ring annuloplasty,
ricuspid regurgitation was zero to mild in 69%, moderate in 14%, moderate to
evere in 7%, and severe in 10%. There was no significant difference between the
wo groups (P  .18). Risk factors for recurrent tricuspid regurgitation included
igher preoperative regurgitation grade, preoperative tricuspid regurgitation without
oncomitant mitral regurgitation, and higher pulmonary artery systolic pressure.
onclusions: Bicuspidization annuloplasty and ring annuloplasty were effective at
liminating tricuspid regurgitation at 3 years postoperatively. Bicuspidization an-
uloplasty is a simple, inexpensive option for addressing functional tricuspid
egurgitation. All patients with moderate-to-severe functional tricuspid regurgitation
hould undergo tricuspid annuloplasty regardless of the technique used.
epair of functional tricuspid regurgitation (TR) is a challenging problem.
With relatively few definitive clinical studies to guide management deci-
sions, cardiac surgeons still debate when and how to repair the tricuspidalve. Early investigators advocated a conservative approach, arguing that func-
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1
A
CDional TR, often secondary to pulmonary hypertension and
oncomitant mitral valve disease, should spontaneously im-
rove after mitral valve repair.1 Subsequent studies, how-
ver, have demonstrated that TR does not necessarily re-
ress after repair of left-sided valve lesions.2-7 Uncorrected
R increases both postoperative morbidity and mortality and is
ssociated with poor long-term results with medical manage-
ent alone.8,9 Thus, many cardiac surgeons advocate tricuspid
nnuloplasty at the time of aortic or mitral valve surgery in
atients with moderate or severe TR.10,11 Several annuloplasty
ethods have been described; however, few studies have eval-
ated and compared the efficacy and durability of these
echniques.12
Suture bicuspidization was originally described by Kay,
aselli-Campagna, and Tsuji13 in 1965 as a technique to
orrect TR. This relatively simple technique involved figure-
f-eight suture plication of the posterior leaflet to reduce an-
ulus size. Bicuspidization, however, has since been super-
eded by other techniques seeking to remodel the annulus by
aintaining a trileaflet valve with a more physiologic, stabi-
ized annulus. These techniques include De Vega’s semicircu-
ar annuloplasty14 and the use of prosthetic annuloplasty rings,
uch as the Carpentier-Edwards semirigid ring (Edwards Life-
ciences, Irvine, Calif),10 the Cosgrove-Edwards flexible band
Edwards LifeSciences),15 and the Duran flexible ring.16 A
mall number of studies comparing ring annuloplasty with
uture annuloplasties (primarily the De Vega) have concluded
hat ring annuloplasty offers a more durable repair and that ring
nnuloplasty should supplant suture annuloplasty for repair of
unctional TR.12,17-19 Other investigators have reported good
xperience with the De Vega annuloplasty and continue to
dvocate its use.20,21 In North America, most surgeons cur-
ently favor ring annuloplasty.
At our institution, we routinely perform a modified su-
ure bicuspidization of the tricuspid valve or a ring annulo-
lasty in all patients with moderate-to-severe functional TR
ho present for cardiac surgery. Since the dilation of the
ricuspid valve primarily occurs at the posterior leaflet,
osterior suture bicuspidization offers an inexpensive,
Abbreviations and Acronyms
ACC  American College of Cardiology
AHA  American Heart Association
AI  aortic insufficiency
EF  ejection fraction
LV  left ventricular
MR mitral regurgitation
NYHA New York Heart Association
PASP  pulmonary artery systolic pressure
RV  right ventricular
TR  tricuspid regurgitationimple, and rapid repair. Bicuspidization may have a role, I
18 The Journal of Thoracic and Cardiovascular Surgery ● Januarticularly in cases of moderate TR, where a simple
epair may be all that is required. The option to perform
simple repair without significantly prolonging operative
ime or requiring a prosthetic ring is appealing. In this
tudy, we review and compare our experience with bi-
uspidization and ring annuloplasty for repair of func-
ional TR to determine the efficacy and durability of
ricuspid annuloplasty.
atients and Methods
atients
rom January 1999 to December 2003, 237 patients underwent
ricuspid annuloplasty for functional TR as part of their cardiac
urgical procedure at the Brigham and Women’s Hospital. Patients
ere identified and preoperative, operative, and postoperative vari-
bles were retrieved from the prospective Brigham Cardiac Sur-
ery Database.
Suture bicuspidization was performed in 157 (66%) patients.
ing annuloplasty was performed in 80 (34%) patients. Of those
ndergoing ring annuloplasty, 60 (75%) patients received a Cosgrove-
dwards flexible band (Edwards LifeSciences), 13 (16%) a Carpentier-
dwards semirigid ring (Edwards LifeSciences), and 7 (9%) a
arbomedics Annuloflex ring (Sulzer Carbomedics, Inc, Austin,
ex). Annuloplasty type depended on surgeon preference. Seven
urgeons contributed patients to this study.
Patient preoperative and surgical characteristics are given in Table
. The mean age of the patients was 67 years (range 20-90 years) and
3% were women. Fifty-three percent of patients were in New York
eart Association (NYHA) functional class III or IV. Concomitant
itral valve surgery was performed in 82% of patients, coronary
rtery bypass grafting in 32%, and aortic valve surgery in 29%. Triple
alve surgery was performed in 53 (22%) patients. Only 23 (9.7%)
atients had tricuspid valve repair as the sole valve procedure. There
as no significant difference between the bicuspidization and ring
nnuloplasty patients in age, gender, NYHA class, preoperative pul-
onary artery systolic pressure (PASP), preoperative right ventricular
RV) dysfunction, and concomitant surgical procedures. RV dysfunc-
ion was defined as any impairment in RV contraction noted on
chocardiography. Left ventricular ejection fraction (EF) was higher
n patients undergoing bicuspidization annuloplasty than in those
ndergoing ring annuloplasty (49% vs 43%, P  .004). The bicus-
idization annuloplasty patients also had a higher prevalence of aortic
nsufficiency (AI) than the ring annuloplasty patients (P  .01).
Preoperative TR was 4 (severe) in 35% of patients, 3 (mod-
rate to severe) in 25%, and 2 (moderate) in 35% (Table 1). Median
R was 3 for both groups. There was a higher percentage of patients
ith 3 to 4 TR in the ring annuloplasty group than in the
icuspidization annuloplasty group (67% vs 57%; P  .03), and the
ean TR was worse in the ring group (3.1 vs 2.8; P  .03).
perative Techniques
ll annuloplasties were performed during concomitant aortic
nd/or mitral valve surgery with cardioplegic arrest. Ring annulo-
lasty was performed by standard operative techniques.10,15 The
uture bicuspidization technique was performed by placing a dou-
le pledget-supported mattress suture of 2-0 Ethibond (Ethicon,
nc, Somerville, NJ) on a large MH needle from the anteroposte-
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A
CDior commissure to the posteroseptal commissure along the poste-
ior annulus (Figure 1). This double multifilament suture is then
ied down over an obturator, such as the barrel of a 20-mL syringe
r 29-mm valve sizer, which satisfactorily reduces the orifice size
ithout placing undue strain on the annuloplasty repair and oblit-
rates the posterior leaflet. Studies by Deloche and associates22
ave shown that the primary anatomic problem in functional TR is
natomic dilation of the posterior tricuspid annulus, because this is
he only unsupported area of the tricuspid valve ring, as opposed
o the anterior and septal positions. Thus, a posterior annuloplasty
hould be effective for most cases of functional TR. The entire
rocedure may be accomplished in less than 8 minutes and does
ot produce tricuspid stenosis. In all patients, intraoperative transe-
ophogeal echocardiography was performed to confirm elimina-
ABLE 1. Patient preoperative and surgical characteristic
Overall
haracteristic No. %
o. of patients 237
ge (y  SD) 67 14
emale gender 126 53.2
reoperative NYHA
Class III 81 34.2
Class IV 45 19.0
reoperative TR grade
0 (none) 0 0
1 (mild) 10 4.2
2 (moderate) 84 35
3 (moderate to severe) 59 24.9
4 (severe) 84 35.4
reoperative MR grade
3 63 26.6
4 117 49.4
reoperative AI grade
3 12 5.1
4 6 2.5
reoperative RV dysfunction 58 24.5
reoperative LVEF 48 16
reoperative PASP 52 16
ypass time (min) 172 82
rossclamp time (min) 114 58
oncomitant procedures
MVP/MVR 195 82.2
CABG 76 32.1
AVP/AVR 69 29.1
PVR 4 1.7
Other 13 5.5
ing annuloplasty type
Carpentier-Edwards
Cosgrove-Edwards
Carbomedics Annuloflex
D, Standard deviation; NYHA, New York Heart Association; TR, tricus
entricular; LVEF, left ventricular ejection fraction (%  SD); PASP, pulmo
itral valve replacement; CABG, coronary artery bypass grafting; AVP,
eplacement; NS, not significant.ion of TR. w
The Journal of Thoracicollow-up
he status of all patients was assessed cross-sectionally in 2005.
ollow-up data (vital status, functional status, and/or postoperative
chocardiograms) were obtained for 234 (99%) patients. Echocar-
iographic reports were solicited from the Brigham and Women’s/
artners HealthCare clinical database or obtained from the pa-
ient’s cardiologist. Postoperative echocardiograms were available
or 210 (89%) patients. The Social Security Death Index was used
o determine vital status. Surviving patients were assessed by
elephone interviews with questionnaires approved by the institu-
ional review board. Mean follow-up time was 3 years. Functional
tatus and occurrence of subsequent cardiac operations were de-
ermined. A total of 540 patient-years of follow-up information
rall and by annuloplasty type
Bicuspidization Ring
P valueo. % No. %
57 66.2 80 33.8
66 14 68 14 NS
82 52.2 44 55.0 NS
54 34.4 27 33.8
27 17.8 17 21.3
.03
0 0 0 0
8 5.1 2 2.5
60 38.2 24 30.0
42 26.8 17 21.3
47 29.9 37 46.3
NS
44 28.6 19 24.1
76 49.4 41 51.9
.01
11 7.0 1 1.3
4 2.6 2 2.5
34 21.7 24 30.0 NS
50 15 43 18 .004
51 17 52 15 NS
163 77 190 88 .02
108 53 125 66 .07
NS
33 84.7 62 77.5
47 29.9 29 36.3
48 30.6 21 26.3
2 1.3 2 2.5
5 3.2 8 10
13 16.3
60 75.0
7 8.8
gurgitation; MR, mitral regurgitation; AI, aortic insufficiency; RV, right
artery systolic pressure (mm Hg  SD); MVP, mitral valvuloplasty; MVR,
ic valvuloplasty; AVR, aortic valve replacement; PVR, pulmonary valves ove
N
1
1
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nary
aortas available for analysis.
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1
A
CDssessment of Repair
reoperative and postoperative transesophageal echocardiographic
eports were used to assess TR grade. Interpretation of follow-up
chocardiograms was obtained at as many time points as available
or each patient. Transesophageal echocardiographic data were
xcluded so that TR grade determination would be consistent
etween patients and time points. A total of 519 postoperative
chocardiographic reports were obtained. Twenty-seven patients
ad no postoperative echocardiograms available for analysis and
ere excluded. Median time of echocardiographic assessment was
year (25th percentile  1 week, 75th percentile  1.5 years,
ange  0-4.7 years). TR was graded as 0 for no regurgitation, 1
or mild, 2 for moderate, 3 for moderate to severe, and 4 for
evere, as defined by the American Society of Echocardiography.
nd Points
e sought to address the following questions:
1. What is the efficacy and durability of tricuspid annuloplasty
with suture bicuspidization and ring annuloplasty over the
midterm postoperative period?
2. How does bicuspidization annuloplasty compare with ring
annuloplasty?
3. What is the survival of patients after tricuspid valve repair?
4. What is the functional improvement after tricuspid valve
repair?
5. What are the risk factors for repair failure?
ata Analysis
reoperative variables were compared between groups by the
isher exact test (categorical variables) and the Student t test
continuous variables). Kaplan–Meier analysis was used to evalu-
te mortality and development of 2 (moderate) recurrent TR.23
n the Kaplan–Meier analysis, development of 2 TR was defined
s the presence of sustained 2 TR on serial echocardiograms.
atients were censored at time of mortality or last follow-up. To
valuate TR (mean TR and TR grade) over time, we performed
epeated-measures mixed models (using SAS Proc Mixed; SAS
nstitute, Inc, Cary, NC) and longitudinal ordinal logistic regres-
ion (using SAS Proc Glimmix) for each annuloplasty tech-
igure 1. Suture bicuspidization is performed by placement of a
-0 pledget-supported Ethibond mattress suture from the antero-
osterior to the posteroseptal commissures along the posterior
nnulus.ique.24,25 These longitudinal methods ensure that patients with c
20 The Journal of Thoracic and Cardiovascular Surgery ● Januore repeat echocardiograms and/or more follow-up are not given
xcessive weight and do not have a disproportionate influence on
stimated means and proportions over time. We performed a
imilar longitudinal regression on postoperative recurrent mitral
egurgitation (MR) to evaluate the effect of MR on TR. To
valuate the risk factors for development of higher recurrent post-
perative TR, we performed univariate followed by multivariate
ox regression. Because there were preoperative differences in
R, EF, and AI between the bicuspidization and ring annuloplasty
roups, weighted propensity score adjustment was performed to
etter compare the two groups when performing the longitudinal
nd survival analyses for recurrent TR.26 In this propensity score
pproach, the data for each patient are weighted by the inverse of
he probability of receiving his or her treatment given the preop-
rative TR, EF, and AI. This propensity score analysis ensures that
he effect of treatment is not confounded by the fact that bicus-
idization patients tended to have better lower preoperative TR,
etter EF, and higher prevalence of AI. In all analyses, both
eighted and unweighted comparisons were performed.
esults
ardiopulmonary Bypass and Aortic Crossclamp
imes
atients who underwent bicuspidization annuloplasty with
oncomitant left-sided valve procedures had a mean cardio-
ulmonary bypass time of 163  77 minutes and an aortic
rossclamp time of 108  53 minutes. Ring annuloplasty
atients had times of 190  88 minutes and 125  66
inutes, respectively (Table 1). Cardiopulmonary bypass
nd aortic crossclamp times were thus 27 minutes (P .02)
nd 17 minutes (P  0.07) shorter, respectively, in the
icupsidization patients. Controlling for number of concom-
tant procedures, there was no statistically significant dif-
erence in operative times between surgeons (P  .7).
ortality, Reoperations, and Functional Improvement
here were 10 (6.4%) early deaths (within 30 days or during
he same hospitalization after the operation) in the bicus-
idization annuloplasty group and 9 (11.3%) early deaths in
he ring annuloplasty group. The Kaplan–Meier survival
urve is shown in Figure 2. There was no statistically
ignificant difference in mortality between the two groups;
owever, the ring annuloplasty patients demonstrated a
rend to poorer survival (P  .07). Interestingly, the ring
roup had a lower preoperative EF and higher preoperative
R than the bicuspidization group. This may account for the
rend to poorer survival. There was no statistically signifi-
ant difference (P  .37) in mortality in patients who had
ignificant recurrent TR. The actuarial survival at 3 years
ostoperatively was 75.3% in the bicuspidization group and
1.2% in the ring annuloplasty group.
Only 6 patients underwent reoperative valve surgery during
he follow-up period of this study. Of these, only 1 (0.4%)
atient underwent a reoperative tricuspid valve repair. NYHA
lass significantly improved for both groups (P  .05). Pre-
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A
CDperatively, 45.8% of bicuspidization and 43.2% of ring an-
uloplasty patients were in NYHA class III or IV. At follow-
p, 15% of bicuspidization and 14% of ring patients remained
n class III or IV. The mean NYHA class improved from 2.3
o 1.6 with bicuspidization and from 2.4 to 1.5 in ring annu-
oplasty patients.
fficacy and Durability of Tricuspid Annuloplasty
o evaluate overall efficacy and durability of annuloplasty,
e evaluated TR grades by 3 different methods. We deter-
Figure 2. Kaplan–Meier survival analysis.The Journal of Thoracicined TR grade at last follow-up, assessed freedom from
evelopment of 2 TR over time using Kaplan–Meier
nalysis (Figure 3), and used the serial echocardiographic
ata to predict mean TR and TR prevalence over time using
ongitudinal regression analyses (Figure 4). All annulo-
lasty types proved efficacious at reducing TR. Mean TR
rade decreased by approximately 40% in both groups from
efore the operation to the last follow-up. The mean TR
rade for each group was 3 preoperatively and improved
Figure 3. Kaplan–Meier analysis of freedom from moderate TR.
Figure 4. Predicted mean TR
and TR prevalence using pro-
pensity score–adjusted longitu-
dinal regression. A, Mean TR
over time for both groups. B,
Percentage of patients in each
group in whom the development
of 3 or 4 TR is predicted over
time. C, Predicted prevalence of
TR grades after bicuspidization.
D, Predicted prevalence of TR
grades after ring annuloplasty.
TR, tricuspid regurgitaton.and Cardiovascular Surgery ● Volume 133, Number 1 121
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1
A
CDo 2 TR at last follow-up. TR, however, was not signifi-
antly reduced in all patients. At last echocardiographic
ollow-up, TR in bicuspidization annuloplasty patients was
ero to mild in 75%, moderate in 11%, moderate to severe
n 6%, and severe in 8%. In ring annuloplasty patients, TR
as zero to mild in 69%, moderate in 14%, moderate to
evere in 7%, and severe in 10%. There was no statistically
ignificant difference in mean TR grade or prevalence of TR
t last follow-up between the two groups (P  .18). Be-
ween the different ring annuloplasty techniques, there was
o statistically significant difference in mean TR grades at
ast follow-up (P . 21). In the Cosgrove-Edwards band
roup, 7 (12%) patients had 3 or 4 recurrent TR at last
ollow-up, compared with 1 (8%) patient in the Carpentier-
dwards ring group.
Figure 3 demonstrates the Kaplan–Meier analysis of
reedom from moderate TR over time for both groups.
here was no significant difference between the two groups
n the Kaplan–Meier analysis (P  .16 weighted by pro-
ensity score; P  .13 unweighted). At 3 years postopera-
ively, 75% of bicuspidization and 69% of ring annuloplasty
atients had zero to mild TR. In the majority of the 44
atients in whom moderate or greater recurrent TR devel-
ped, it did so within the first 6 months in both groups. The
edian time to development of moderate TR in these 44
atients was 46 days (25th percentile  10 days, 75th
ercentile  286 days, range  0-4.9 years).
Figure 4 demonstrates the predicted TR prevalence over
ime for both groups. The evolution of TR is similar be-
ween both groups. Mean TR drops significantly postoper-
tively, increases in the next 6 months, continues to grad-
ally increase up to 2 years postoperatively, and then
emains relatively unchanged up to 3 years postoperatively
Figure 4, A). The percentage of patients with 3 and 4
ABLE 2. Risk factors for development of higher recurrent TR
isk factor
Coefficient
( SE) Hazard ratio P value
ge .01  .01 0.990 0.35
ender .15  .33 0.264 0.66
reoperative NYHA .07 .20 1.076 0.71
nnuloplasty type .45  .30 0.640 0.14
reoperative TR 1.29 .34 4.031 0.001
reoperative EF .03 .02 1.027 0.08
reoperative MR .24  .11 0.786 0.04
reoperative PASP .004 .02 0.996 0.81
reoperative RV dysfunction .04 .53 1.044 0.94
ostoperative PASP .05 .02 1.056 0.01
R, Tricuspid regurgitation; SE, standard error; NYHA, New York Heart
ssociation; EF, ejection fraction; MR, mitral regurgitation; PASP, pulmo-
ary artery systolic pressure; RV, right ventricular.R is the same between the two groups (Figure 4, B). The m
22 The Journal of Thoracic and Cardiovascular Surgery ● Januistribution of TR grades is also similar between the two
roups (Figure 4, C and D).
isk Factors for Repair Failure
ccording to the Cox proportional hazards model, higher
reoperative TR and the presence of preoperative TR with
ower concomitant preoperative MR were found to be risk
actors for development of recurrent TR (Table 2). Higher
eft ventricular EF demonstrated a trend to being a risk
actor for significant recurrent TR. In patients with better
eft heart function (ie, better left ventricular EF and lower
R), preoperative TR may indicate a greater degree of
alve dysfunction, such as annular dilation or valve tether-
ng, which may be less amenable to repair.27 Significantly,
ricuspid annuloplasty type was not found to be a risk factor
or recurrent TR. Preoperative and follow-up NYHA class
ere also not found to be significant factors. Of the 19
atients in NYHA class III or IV, only 4 (17%) had 2 or
reater TR at last follow-up. There was no statistically
ignificant difference (P  .32) in prevalence of TR be-
ween patients in NYHA class I/II and those in NYHA class
II/IV. Similarly, preoperative PASP and RV dysfunction
ere not found to be risk factors for recurrent TR. To
valuate whether there was a correlation between postoper-
tive PASP and tricuspid repair failure, we determined the
ASP at the time of failure (from the echocardiographic
ata) and, using a time-varying covariate Cox model, com-
ared it with patients whose repair did not fail. Higher
ostoperative PASP was a significant risk factor for repair
ailure, regardless of annuloplasty type. PASP was higher in
atients who had unsuccessful annuloplasty than in patients
ho did not (Table 3).
To evaluate whether there was a correlation between left
eart valve repair failure and tricuspid repair failure, we
etermined the predicted mean MR over time in patients in
hom moderate recurrent TR developed postoperatively.
here was no correlation between tricuspid repair failure
nd recurrent MR. Other studies, by Matsunaga,28 Drey-
us,29 and their associates, have also demonstrated a lack of
orrelation between recurrent MR and recurrent TR after
ABLE 3. Preoperative and follow-up PASP in patients
ith and without 2 recurrent TR
Preoperative
PASP
(mm Hg)
Follow-up
PASP
(mm Hg)
ith recurrent TR (n  44) 51  16 52  16
ithout recurrent TR (n  193) 52 16 43  12
ASP, Pulmonary artery systolic pressure; TR, tricuspid regurgitation;
ollow-up PASP, PASP at time of development of 2 recurrent TR or at last
ollow-up.itral valve surgery.
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A
CDiscussion
ew studies have evaluated the long-term outcomes of
ricuspid valve annuloplasty. The decision to perform an
nnuloplasty is often dictated by institutional or surgeon
ias, with little objective data to guide decision making.
ost series of tricuspid valve repairs are small and focus on
utcomes such as survival and freedom from reoperation.
urvival itself may be dependent on multiple factors and is
ot necessarily related to the tricuspid annuloplasty. Free-
om from reoperation may not take into account many
atients who have high rates of recurrent TR, but are not
ffered surgery owing to operative risk.8 Despite logistical
nd statistical challenges, a better outcome to evaluate is the
egree of TR, as this is typically the indication for
peration.30
In this study, we have evaluated TR over time after
icuspidization and ring tricuspid annuloplasty. In our ex-
erience, both bicuspidization and ring annuloplasty pro-
uce an effective, durable repair at 3 years postoperatively.
ignificant 3 or 4 residual TR occurred in 8% of pa-
ients early after operation for all types of annuloplasty.
hese results are similar to a previous study performed by
cCarthy and colleagues.12 Their detailed study of 790 pa-
ients found that 14% of patients had 3 or 4 residual TR
arly after operation for all annuloplasty types, but ring repairs
Carpentier semirigid ring and Cosgrove–Edwards flexible
and) provided a more durable repair than suture annuloplasty
ver an 8-year period. In McCarthy’s study,12 at 3 years
ostoperatively, 3 or 4 TR occurred in approximately 25%
f De Vega patients, 27% of Peri-Guard (Bio-Vascular, Inc, St
aul, Minn) patients, 15% of Carpentier–Edwards ring pa-
ients, and 18% of Cosgrove-Edwards band patients. In this
tudy, 16% of bicuspidization and 18% of ring annuloplasty
atients had 3 or 4 TR at 3 years postoperatively. Thus, at
years, our outcomes with suture bicuspidization were supe-
ior to the De Vega and Peri-Guard annuloplasties and equiv-
lent to ring annuloplasty outcomes presented in the McCarthy
tudy.
Suture annuloplasties, particularly the continuous run-
ing type, like the De Vega,14 have been criticized for being
npredictable and unreliable, perhaps owing to the long
uture line or the use of polypropylene suture material,
hich may break and slide through the tissue as the annulus
ilates.31 Bernal and colleagues,20 however, have reported
xcellent results in 232 patients with the De Vega annulo-
lasty at 6.8 years postoperatively, with 86% of patients
aving zero to mild TR. Similar to the Revuelta segmental
nnuloplasty, the posterior suture bicuspidization technique
escribed in this article is performed with a braided, mul-
ifilament suture (2-0 Ethibond).32 This suture is less likely
o break and thus provides a more durable repair to the area
hat primarily dilates to produce functional TR. This repair
ay be performed in less than 8 minutes. In this study, we p
The Journal of Thoracicound that cardiopulmonary bypass and aortic crossclamp
imes were 27 minutes and 17 minutes shorter in the bicus-
idization group. Since there were no differences in the
umber and distribution of concomitant procedures between
he two groups, the reduced cardiopulmonary bypass and
ortic crossclamp times were primarily because of the faster
ricuspid annuloplasty performed.
Despite 40 years of evolving annuloplasty techniques,
here has been no consensus on the management of func-
ional TR. Recent guidelines from the American College of
ardiology (ACC) and American Heart Association (AHA)
ecommend tricuspid annuloplasty during mitral or aortic
alve surgery in patients with severe TR.33 Although most
urgeons agree that a patient with severe, symptomatic TR
equires repair, many surgeons favor a conservative ap-
roach in patients with only moderate TR. The ACC/AHA
uidelines suggest that functional TR without annular dila-
ion or significant pulmonary hypertension does not require
epair.33 There is a growing body of information, however,
hat the conservative approach is ineffective and that a
ubstantial number of patients will be left with residual TR,
hich is associated with increased perioperative and late
ostoperative morbidity and mortality.6,8,9,28 In this study,
ignificant 3 or 4 early residual TR developed in 8% of
atients and 2 or greater TR developed within 3 years in
7% of patients. Although these results are inferior to out-
omes of mitral valve repair, tricuspid annuloplasty was effec-
ive in the majority of patients and may be significantly better
han the alternative—no repair. Matsunaga and Duran28 have
ecently reported that 53% (10/19) of patients have 2 or
reater TR at 3 years after mitral valve repair alone. Mat-
uyama and colleagues7 recently reported that 37% (17/46) of
atients with 2 preoperative TR have 3 or 4 TR at 8
ears after mitral valve repair alone. It should be noted that, in
he Matsunaga study, only 30% of patients had 2 or greater
reoperative TR. In this study, 96% of patients had 2 or
reater TR preoperatively. Thus, the difference between con-
ervative management and tricuspid annuloplasty may be even
ore pronounced in patients with 3 or 4 TR. A prospective
tudy may be indicated to definitively compare conservative
anagement versus tricuspid annuloplasty.
Previously, patients with zero to mild TR have demon-
trated a significantly lower mortality than patients with
oderate-to-severe TR.9 At 3 years, 73% of patients in this
tudy had zero to mild TR. Thus, we believe that tricuspid
nnuloplasty should be performed not only in patients with
evere TR, but in all patients with even moderate TR,
specially when an effective annuloplasty technique can be
erformed rapidly and reproducibly. Dreyfus and col-
eagues29 even advocate that any patient with substantial
nnular dilation should undergo repair regardless of TR
rade or even no TR. We believe that our suture bicus-
idization is a relatively simple, inexpensive technique that
and Cardiovascular Surgery ● Volume 133, Number 1 123
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CDan be performed rapidly and should be used in all patients
ith at least moderate TR who present for left-sided valve
urgery. In our experience, this technique has been as ef-
ective as ring annuloplasty in the midterm postoperative
eriod.
imitations
his study has several limitations. First, the echocardio-
raphic data obtained are subject to significant selection and
scertainment bias. Symptomatic patients were probably
ore likely to receive follow-up echocardiography than
symptomatic patients. Even though the statistical methods
sed23,24 adjust for such follow-up data, the true TR prev-
lence may in fact have been lower if all patients were
outinely screened with echocardiography. Second, this is a
etrospective review and, as such, patients were not ran-
omized, creating an inherent selection bias with regard to
he annuloplasty performed. Although the two groups were
ery similar, the ring annuloplasty group had slightly worse
reoperative TR and left ventricular EF. We adjusted for
his difference using propensity scores, and there was no
ifference in the findings with and without adjustment.
hird, the ring annuloplasty group was a composite of
hree different prosthetic annuloplasty techniques. The
osgrove–Edwards band, the Carpentier–Edwards ring, and
he Carbomedics Annuloflex ring are different prosthetic
nnuloplasty systems, each with different sizes, shapes, and
igidities. We did find a lower percentage of patients with
ecurrent 3 or 4 TR who received the Carpentier–
dwards semirigid ring compared with the Cosgrove–
dwards flexible band. However, we did not have a suffi-
ient number of patients to compare each subgroup. No
tudy, however, has demonstrated that any one of these
rosthetic annuloplasties is superior to the others. There-
ore, we believe it is appropriate to combine these annulo-
lasties into a single group to simplify the comparison of
rosthetic annuloplasty with suture bicuspidization.
onclusions
n summary, we have demonstrated that bicuspidization
nnuloplasty and ring annuloplasty for functional TR were
qually efficacious and durable at reducing TR up to 3 years
ostoperatively. Significant residual TR occurred in 8% of
atients early after annuloplasty. Sixty-nine percent of ring
nnuloplasty and 75% of bicuspidization annuloplasty pa-
ients remained free from moderate TR in the midterm
ostoperative period. Risk factors for annuloplasty failure
ncluded greater preoperative TR grade, preoperative TR
ithout concomitant MR, and higher postoperative PASP.
YHA, preoperative PASP, preoperative RV dysfunction,
nd recurrent MR were not significant risk factors.
Bicuspidization annuloplasty is inexpensive, simple toerform, and reduces operative time. Our experience sug-
24 The Journal of Thoracic and Cardiovascular Surgery ● Januests that bicuspidization annuloplasty is a reliable method
or tricuspid annuloplasty and should be given consideration
hen approaching every patient with functional TR under-
oing aortic or mitral valve surgery.
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iscussion
r P. McCarthy (Chicago, Ill). Congratulations, Dr. Ghanta, on
n excellent paper and presentation. They say that beauty is in the
ye of the beholder—and so it is with this paper from the Brigham
egarding tricuspid valve repair in patients with functional TR.
ne could say that the results of bicuspidization for TV repair are
qual to that of ring annuloplasty, but one could also say that both
re equally bad. Three years postoperatively, 3 or 4 TR was
resent still in 25% of the bicuspidization patients and 31% of the
ing patients. These are clearly not results that we would accept in
atients undergoing valve repair for a condition such as myxoma-
ous mitral regurgitation, for which we are now recommending
urgery for patients with asymptomatic disease, because the repairs
re very durable.
For some reason, we as surgeons have come to accept that a
ignificant percentage of our patients who undergo tricuspid repair
ill redevelop significant TR. While it may not always be clini-
ally significant early after surgery, increasing clinical evidence
ndicates that over time the patient will suffer for this.
I would like to note one clarification regarding your paper.
our grading of TR indicates that moderate is 3. This is consis-
ent with the STS database. Unfortunately, we have a disconnect
ith our colleagues in cardiology such that the American Society t
The Journal of Thoracicf Echo refers to 3 regurgitation as moderate to severe, and in
heir system moderate is only 2. Just to clarify for the audience,
hen, when you are referring to moderate regurgitation in this
aper, it is 3. Anytime we see a patient who redevelops 3 or 4
egurgitation, we should consider that a failure of the repair tech-
ique.
I have three questions. Your study has the usual problems with
retrospective study in that the patients treated with a ring had at
aseline lower ejection fractions and worse tricuspid regurgitation,
oth very significant risk factors for failure in our study from the
leveland Clinic. The propensity matching helps to control for this
iscrepancy. But seeing that we are mostly a group of surgeons and
ot statisticians, did there appear to be a bias towards using a ring
or worse patients, or was the use of the different techniques
imply due to surgeon preference in this group practice?
Dr Ghanta: Thank you very much, Dr. McCarthy. I agree with
ou that there is probably some bias in what type of procedure
atients may have. If they have very severe TR and are symptom-
tic, they probably were more likely to get a ring at our institution
han a bicuspidization repair. However, there was a small differ-
nce in the actual distribution of preoperative TR grades between
he two groups; the mean TR was 3.4 in the bicuspidization group
nd 3.5 in the other group. Sixty-seven percent of the patients in
he ring group had severe TR preoperatively, and 56% of the
atients had severe TR in the bicuspidization group preoperatively.
And I would agree with you that a 75% and 69% success rate
t three years may be marginally acceptable. However, it might be
etter than the alternative, which is no repair. We converted
atients who were preoperatively moderate/severe-to-severe TR to
ild TR at three years. Looking at the mortality study done by
aff and colleagues in the Journal of the American College of
ardiology, mild TR had significantly better survival in compar-
son to moderate TR as an independent risk factor. So although we
hould develop, ideally, better techniques and get better results, the
esults that we outlined here may be better than the alternative,
hich is no repair at all.
Dr McCarthy. I certainly agree with that. Also, we should be
ooking at doing earlier repairs and lower the threshold, for which
e would do a repair in this group of patients.
In our paper permanent pacing wires and ICD wires that cross
he tricuspid valve led to our highest risk for recurrence, especially
ate. By 5 years, 42% of those patients had redeveloped 3 or 4
R. Do you have any data on the use of pacemakers in your
atients, especially for the group with low ejection fractions that
hese days are treated with biventricular pacemakers, and did some
f those patients receive late pacemakers?
Dr Ghanta. None of our patients preoperatively had permanent
acemakers in place. Postoperatively, 23 (or 10%) patients re-
uired pacemakers. There was no difference between the bicus-
idization and ring annuloplasty groups in the number of patients
ho got permanent pacemakers after the operation. Six patients
eveloped a complete heart block—three in the ring and three in
he bicuspidization group.
We looked to see how many of the patients who required
acemakers developed moderate residual TR. Surprisingly, it
urned out that only 4 of those patients actually developed mod-
rate residual TR within the time period of this study. All 4 of
hose patients happened to be in the ring group, but the numbers
and Cardiovascular Surgery ● Volume 133, Number 1 125
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CDre so small that we can’t draw any meaningful conclusions behind
t. I know your study, which had 790 patients, did show that the
resence of pacemaker leads increased the risk of residual TR.
Dr McCarthy. Finally, in a follow-up study from our echo
roup, we found that tricuspid valve tethering due to a very dilated
ight ventricle was a very strong predictor for recurrent TR. This
akes sense with what we know now of mitral valve tethering
ith functional mitral regurgitation due to LV dysfunction. Do you
ave any information on other echo findings, such as right ven-
ricular dilatation, tricuspid valve tethering, RV function, and
ould you anticipate that for that group you may do a more
ggressive repair?
Dr Ghanta. Thank you. We actually do not have that infor-
ation as it is not routinely obtained in echocardiograms, but I
gree with you that it is probably very important in determining the
utcomes of tricuspid valve repair. We do need to look at the
unction of the right ventricle so that we can better determine the
ikelihood of repair being a success. Tethering may be present, and
f tethering is present it may indicate that the patient should get a
eplacement as opposed to a repair. This is something that we
ould very much like to look at in the future.
Dr H. Bolooki (Miami, Fla). Congratulations, this is a very
ice study and a fine presentation of a large number of patients. In
upport of your work, I would like to indicate that I don’t use a ring
o repair a functionally incompetent tricuspid valve. I have done
he procedure that you are describing for over 20 years. Our
echnique may be slightly different. In the very first case in early
0s we used only one suture to plicate the lateral leaflet. That did
ot work for long and within one year we had tricuspid insuffi-
iency needing urgent repair. A more complete and secure suturing
ethod that I call “triple suture, triple bite technique” was used
hereafter in all instances, which is similar to your method. The
titches follow the right lower quadrangle of the annulus from
hree o’clock to six o’clock and it works very well. It has not come
oose and has not cut through the annulus. The immediate intra-
perative echocardiogram shows minimal insufficiency, and the
ailure rate or 3 insufficiency has been less than 20% over 10
ears. Failure of the repair, however, has always followed the
ecurrence of mitral pathology.
I would like to ask, if late tricuspid insufficiency—say, 3 or
s—returns, what you do when you go back? Do you re-repair
hese, put a ring on, or change the tricuspid valve? Thank you very
uch.
Dr Ghanta. Thank you. In our group of patients we only had
who required a reoperation, and only one of those patients, or
.4%, required reoperation on the tricuspid valve. The other five
equired reoperation on the mitral valve.
We recently had a case at our hospital in which a patient had a
itral valve repair and tricuspid valve repair with a Cosgrove- i
26 The Journal of Thoracic and Cardiovascular Surgery ● Janudwards ring at an outside institution. The patient developed
ecurrent severe tricuspid regurgitation. The patient was taken to
he operating room, had the ring removed, and received a bicus-
idization annuloplasty, which eliminated the TR. This was done
ust two weeks ago. So it is possible to do reoperative procedures
sing the bicuspidization technique.
Dr D. Adams (New York, NY). I wanted to follow up on a
uestion that Dr. McCarthy asked you. That is about the mecha-
ism. It is really not residual; it is recurrent tricuspid regurgitation
n your series. Ventricular-related leaflet restriction is the most
ikely reason for that. I think a remodeling annuloplasty that really
xes the annulus is more effective for that type of mechanism, and
o you agree that the same mechanism for recurrent TR is prob-
bly right ventricular dysfunction?
The other thing that you didn’t mention and that I would like
or you to comment on is the difference in pulmonary hypertension
etween your groups, because that is obviously an important
ariable.
Finally, I would be careful trying to use operative times as a
ustification. We know Dr. Cohn is very fast, and we know which
echnique he likes to use! I believe a remodeling annuloplasty adds
bout 8 or 10 minutes to the procedure, and I think the long-term
urability may be worth it.
Thank you.
Dr Ghanta. We did not look at pulmonary pressures in this
tudy. That data was not catalogued and was not consistently
vailable in all patients, but it would be definitely worth looking at.
Dr G. Dreyfus (Middlesex, United Kingdom). I want to con-
ratulate you on your presentation; however, it seems really that
eshaping the tricuspid annulus similarly to the mitral valve does
rovide, at least in your series, similar results to this bicuspidiza-
ion technique that you show, which is more a shrinking of the
ricuspid orifice and doesn’t prevent recurrence of tricuspid regur-
itation. I think saying that both methods are showing recurrent
ricuspid regurgitation shows really how difficult it is to assess the
roper timing for surgery and that regurgitation on the right side is
ot a reliable criterion. I mean, once you have got such a tethering
f the papillary muscle, perhaps we should apply to the right side
imilar techniques that we apply to the left side. Rather than
hrinking the orifice, we should deal with the papillary muscle and
he chordae in order to try to overcome the tethering of the right
entricle. Could you comment on that?
Dr Ghanta. We definitely agree with you, and tethering of the
apillary muscle needs to be evaluated. In our study, we didn’t
ave any information regarding the papillary muscle or whether or
ot any tethering was present. But it would definitely be very
nteresting to take a look at.
ary 2007
